Share this article
Share this article
ResearchAndMarkets.com s offering.
The global Patient-Derived Xenograft/PDX models market size is projected to reach USD 299 million by 2026 from USD 140 million in 2021, at a CAGR of 16.4% during the forecast period.
Market growth is driven mainly by factors such as growing demand for personalized medicine, continuous support for cancer research, and growth in pharma R&D. Rising demand for humanized PDX models is expected to provide growth opportunity for players in the PDX models market. However, the high cost of personalized PDX models, stringent guidelines regarding the ethical use of animals in cancer research, and limitations associated with PDX models are expected to restrain the growth of this market to a certain extent during the forecast period.
26
Data Bridge Market Research has recently added a new research report to its mega database of research international studies. The research report, titled “PDX Models Market 2021” identifies and analyses the emerging trends along with major drivers, challenges market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels and opportunities in the market for PDX Models industry. For a thriving business, it is quite essential to get know how of consumer’s demands, preferences, attitudes and their changing tastes about the specific product and this report is right there to solve this purpose. Furthermore, businesses can utilize the information included in this report to decide on their production and marketing strategies. A reliable global PDX Models report is structured with the vigilant efforts of innovative, enthusiastic, knowledgeable and experienced team of analysts, researchers, industry exp